Research progress on the relationship between glucagon-like peptide 1 receptor agonists and thyroid tumors
	    		
		   		
		   			
		   		
	    	
    	 
    	10.3969/j.issn.1006-6187.2024.03.016
   		
        
        	
        		- VernacularTitle:胰高血糖素样肽1受体激动剂与甲状腺肿瘤关系的研究进展
 
        	
        	
        	
        		- Author:
	        		
		        		
		        		
			        		Ziwei LIU
			        		
			        		
			        		
			        			1
			        			
			        		
			        		
			        		
			        		
			        		;
		        		
		        		
		        		
			        		Ling YUE
			        		
			        		
		        		
		        		
		        		
		        		
		        			
			        		
			        		Author Information
			        		
		        		
		        		
			        		
			        		
			        			1. 430065 武汉科技大学医学院
			        		
		        		
	        		
        		 
        	
        	
        	
        	
        		- Keywords:
        			
	        			
	        				
	        				
			        		
				        		Glucagon-like peptide 1 receptor agonists;
			        		
			        		
			        		
				        		Thyroid C cell tumors;
			        		
			        		
			        		
				        		Papillary thyroid carcinoma
			        		
			        		
	        			
        			
        		
 
        	
            
            
            	- From:
	            		
	            			Chinese Journal of Diabetes
	            		
	            		 2024;32(3):235-237
	            	
            	
 
            
            
            	- CountryChina
 
            
            
            	- Language:Chinese
 
            
            
            	- 
		        	Abstract:
			       	
			       		
				        
				        	Glucagon-like peptide 1 receptor agonists(GLP-1 RAs)can improve the adverse outcomes of diabetes mellitus.It can affect the occurrence and development of thyroid C cell tumors by stimulating the abnormal proliferation of thyroid C cells and release of calcitonin in rodents.This article reviews the research progress of GLP-1 RAs and thyroid tumors.